OLYSIO® sales during the fourth quarter 2015
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the global fourth quarter net sales of OLYSIO® (simeprevir) amounted to 44 MUSD.The royalty for the fourth quarter amounted to 31 MSEK (3.4 MEUR). Medivir’s royalties based on sales for the fourth quarter are calculated from the third royalty tier. +---------------------------+--------+-------+-------+|OLYSIO® global net sales |Sales in MUSD | |+---------------------------+--------+-------+-------+|Market |Q4 -2015|Q4-2014|Change |+---------------------------+--------+-------+-----